The National Natural Science Foundation of China(Grant No.81373343 and 81673367)
Drug resistance of anthracycline in the invasive cancer is associated with the lowered cellular drug uptake and diminished co-localization of drug with nuclei. In the present study, we aimed to construct the folate-co...
National Natural Science Foundation of China(Grant No.81373343);the Key Grant of Beijing Natural Science Foundation(Grant No.7131009)
Triple-negative breast cancer is the tumor that lacks expressions of estrogen receptor(ER), progesterone receptor(PR) and human epidermal growth factor receptor-2(HER2). A regular chemotherapy cannot eradicate t...
National Basic Research Program of China(973 Program,Grant No.2013CB932501);Beijing Natural Science Foundation(Grant No.7131009);National Natural Science Foundation of China(Grant No.81373343)
Most of antieancer agents can not be used for treatment of brain glioma due to the existence of the blood brain barrier (BBB). The over-expression of glucose transporters (GLUTs) on the BBB and brain glioma cells ...
National Natural Science Foundation of China(Grant No.81172991 and 81373343)
A single drug chemotherapy fails to eliminate residual cancer cells due to the existence of the multidrug resistance (MDR). In the present study, we aimed to develop a compound epirubicin plus quinine injection, to ...
Beijing Natural Science Foundation(Grant No.7131009);the National Basic Research Program of China(Grant No.973 program,2013CB932501);the National Natural Science Foundation of China(Grant No.81373343);the Innovation Team of Ministry of Education(Grant No.BMU20110263)
Multidrug resistance (MDR) of breast cancer is a major cause of failure in chemotherapy. In the present study, a distearoylphosphatidyl ethanolamine-polyethylene glycol-pemetrexed (DSPE-PEG2000-PMT) conjugate was ...